As of Apr 29
| -2.80 / -2.80%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 115.00, with a high estimate of 145.00 and a low estimate of 90.00. The median estimate represents a +18.39% increase from the last price of 97.14.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.